Ignite Creation Date:
2024-05-06 @ 4:05 PM
Last Modification Date:
2024-10-26 @ 2:03 PM
Study NCT ID:
NCT04862455
Status:
RECRUITING
Last Update Posted:
2024-04-15
First Post:
2021-04-05
Brief Title:
NBTXR3 Radiation Therapy and Pembrolizumab for the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Cancer
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Recurrent Head and Neck Squamous Cell Carcinoma |
| Metastatic Head and Neck Squamous Cell Carcinoma |
Keywords: